PEG-3350 Oral Solution Recalled for Defective Non-Sealed Pouches
A PEG-3350 oral solution is being recalled nationwide due to defective pouches that may not be properly sealed, risking product leakage. The recall affects 13,200 cartons with lot number S300542.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recalls are typically scored 1 or 2. This packaging defect has no reported illnesses or injuries, and the hazard is theoretical. However, the potential for product leakage constitutes a functional packaging defect rather than purely cosmetic, warranting a Moderate classification.
Plain-English summary
PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution is a prescription medication distributed by Teva Pharmaceuticals USA, Inc. The U.S. Food and Drug Administration issued a Class III recall for this product.
The recall was issued because the product containers—specifically the pouches—may not be properly sealed, which could lead to product leakage and compromise the integrity of the medication.
The recall affects 13,200 cartons with lot number S300542 (expiration date June 30, 2025) that were distributed nationwide in the United States. The manufacturer of the recalled product is Novel Laboratories, Inc. d.b.a. Lupin Somerset.
The recalled product
- Product
- PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID (PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID)
- Brand
- PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
- Manufacturer
- Novel Laboratories, Inc. d.b.a Lupin Somerset
- Category
- Drug
- Hazard
- container-defect
- product-leakage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #S300542
- exp. date June 30
- 2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27